| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the New England College of Optometry, Boston, Massachusetts; 2Stony Brook University School of Medicine, Stony Brook, New York; the 3National Eye Institute, Bethesda, Maryland; the 4University of Alabama at Birmingham School of Optometry, Birmingham, Alabama; the 5University of Houston College of Optometry, Houston, Texas; and the 6Pennsylvania College of Optometry, Philadelphia, Pennsylvania.
PURPOSE. The purpose of the Correction of Myopia Evaluation Trial (COMET) was to evaluate the effect of progressive addition lenses (PALs) compared with single vision lenses (SVLs) on the progression of juvenile-onset myopia.
METHODS. COMET enrolled 469 children (ages 6–11 years) with myopia between -1.25 and -4.50 D spherical equivalent. The children were recruited at four colleges of optometry in the United States and were ethnically diverse. They were randomly assigned to receive either PALs with a +2.00 addition (n = 235) or SVLs (n = 234), the conventional spectacle treatment for myopia, and were followed for 3 years. The primary outcome measure was progression of myopia, as determined by autorefraction after cycloplegia with 2 drops of 1% tropicamide at each annual visit. The secondary outcome measure was change in axial length of the eyes, as assessed by A-scan ultrasonography. Child-based analyses (i.e., the mean of the two eyes) were used. Results were adjusted for important covariates, by using multiple linear regression.
RESULTS. Of the 469 children (mean age at baseline, 9.3 ± 1.3 years), 462 (98.5%) completed the 3-year visit. Mean (±SE) 3-year increases in myopia (spherical equivalent) were -1.28 ± 0.06 D in the PAL group and -1.48 ± 0.06 D in the SVL group. The 3-year difference in progression of 0.20 ± 0.08 D between the two groups was statistically significant (P = 0.004). The treatment effect was observed primarily in the first year. The number of prescription changes differed significantly by treatment group only in the first year. At 6 months, 17% of the PAL group versus 30% of the SVL group needed a prescription change (P = 0.0007), and, at 1 year, 43% of the PAL group versus 59% of the SVL group required a prescription change (P = 0.002). Interaction analyses identified a significantly larger treatment effect of PALs in children with lower versus higher baseline accommodative response at near (P = 0.03) and with lower versus higher baseline myopia (P = 0.04). Mean (± SE) increases in the axial length of eyes of children in the PAL and SVL groups, respectively, were: 0.64 ± 0.02 mm and 0.75 ± 0.02 mm, with a statistically significant 3-year mean difference of 0.11 ± 0.03 mm (P = 0.0002). Mean changes in axial length correlated with those in refractive error (r = 0.86 for PAL and 0.89 for SVL).
CONCLUSIONS. Use of PALs compared with SVLs slowed the progression of myopia in COMET children by a small, statistically significant amount only during the first year. The size of the treatment effect remained similar and significant for the next 2 years. The results provide some support for the COMET rationale—that is, a role for defocus in progression of myopia. The small magnitude of the effect does not warrant a change in clinical practice.
This article has been cited by other articles:
|
|
 |
|
  S. Hasebe, H. Ohtsuki, T. Nonaka, C. Nakatsuka, M. Miyata, I. Hamasaki, and S. Kimura Effect of Progressive Addition Lenses on Myopia Progression in Japanese Children: A Prospective, Randomized, Double-Masked, Crossover Trial Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2781 - 2789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-C. Roch-Levecq, B. L. Brody, R. G. Thomas, and S. I. Brown Ametropia, Preschoolers' Cognitive Abilities, and Effects of Spectacle Correction Arch Ophthalmol, February 1, 2008; 126(2): 252 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Y. Tse, C. S. Lam, J. A. Guggenheim, C. Lam, K.-k. Li, Q. Liu, and C.-h. To Simultaneous Defocus Integration during Refractive Development Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5352 - 5359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Jones, L. T. Sinnott, D. O. Mutti, G. L. Mitchell, M. L. Moeschberger, and K. Zadnik Parental History of Myopia, Sports and Outdoor Activities, and Future Myopia Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3524 - 3532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. O. Mutti, J. R. Hayes, G. L. Mitchell, L. A. Jones, M. L. Moeschberger, S. A. Cotter, R. N. Kleinstein, R. E. Manny, J. D. Twelker, K. Zadnik, et al. Refractive Error, Axial Length, and Relative Peripheral Refractive Error before and after the Onset of Myopia Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2510 - 2519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Hrobjartsson, E Forfang, M. Haahr, B Als-Nielsen, and S Brorson Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding Int. J. Epidemiol., June 1, 2007; 36(3): 654 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kurtz, L. Hyman, J. E. Gwiazda, R. Manny, L. M. Dong, Y. Wang, M. Scheiman, and the COMET Group Role of Parental Myopia in the Progression of Myopia and Its Interaction with Treatment in COMET Children Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 562 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. Norton, J. T. Siegwart Jr, and A. O. Amedo Effectiveness of Hyperopic Defocus, Minimal Defocus, or Myopic Defocus in Competition with a Myopiagenic Stimulus in Tree Shrew Eyes Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4687 - 4699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. O. Mutti, G. L. Mitchell, J. R. Hayes, L. A. Jones, M. L. Moeschberger, S. A. Cotter, R. N. Kleinstein, R. E. Manny, J. D. Twelker, K. Zadnik, et al. Accommodative Lag before and after the Onset of Myopia. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 837 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Smith III, C.-s. Kee, R. Ramamirtham, Y. Qiao-Grider, and L.-F. Hung Peripheral Vision Can Influence Eye Growth and Refractive Development in Infant Monkeys Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3965 - 3972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S M Saw, W H Chua, G Gazzard, D Koh, D T H Tan, and R A Stone Eye growth changes in myopic children in Singapore Br. J. Ophthalmol., November 1, 2005; 89(11): 1489 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Dias, E. Schoenfeld, J. Thomas, C. Baldwin, J. Mcleod, J. Smith, R. Owens, and L. Hyman Reasons for high retention in pediatric clinical trials: comparison of participant and staff responses in the Correction of Myopia Evaluation Trial Clinical Trials, October 1, 2005; 2(5): 443 - 452. [Abstract] [PDF]
|
|
|
|
|
|
J R Phillips Monovision slows juvenile myopia progression unilaterally Br. J. Ophthalmol., September 1, 2005; 89(9): 1196 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Jones, G. L. Mitchell, D. O. Mutti, J. R. Hayes, M. L. Moeschberger, and K. Zadnik Comparison of Ocular Component Growth Curves among Refractive Error Groups in Children Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2317 - 2327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Hyman, J. Gwiazda, M. Hussein, T. T. Norton, Y. Wang, W. Marsh-Tootle, D. Everett, and for the COMET Study Group Relationship of Age, Sex, and Ethnicity With Myopia Progression and Axial Elongation in the Correction of Myopia Evaluation Trial Arch Ophthalmol, July 1, 2005; 123(7): 977 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Saw, L. Tong, W.-H. Chua, K.-S. Chia, D. Koh, D. T. H. Tan, and J. Katz Incidence and Progression of Myopia in Singaporean School Children Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 51 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Walline, L. A. Jones, D. O. Mutti, and K. Zadnik A Randomized Trial of the Effects of Rigid Contact Lenses on Myopia Progression Arch Ophthalmol, December 1, 2004; 122(12): 1760 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Siatkowski, S. Cotter, J. M. Miller, C. A. Scher, R. S. Crockett, G. D. Novack, and for the US Pirenzepine Study Group Safety and Efficacy of 2% Pirenzepine Ophthalmic Gel in Children With Myopia: A 1-Year, Multicenter, Double-Masked, Placebo-Controlled Parallel Study Arch Ophthalmol, November 1, 2004; 122(11): 1667 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhong, J. Ge, H. Nie, and E. L. Smith III Compensation for Experimentally Induced Hyperopic Anisometropia in Adolescent Monkeys Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3373 - 3379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Gwiazda, L. Hyman, T. T. Norton, M. E. M. Hussein, W. Marsh-Tootle, R. Manny, Y. Wang, and D. Everett Accommodation and Related Risk Factors Associated with Myopia Progression and Their Interaction with Treatment in COMET Children Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2143 - 2151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Byth and V. Gebski Factorial designs: a graphical aid for choosing study designs accounting for interaction Clinical Trials, June 1, 2004; 1(3): 315 - 325. [Abstract] [PDF]
|
|
|
|
|
|
X. Zhu, J. A. Winawer, and J. Wallman Potency of Myopic Defocus in Spectacle Lens Compensation Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2818 - 2827. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
